Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

In Conversation with Willow Biosciences – Perspectives from an Analyst & CEO

Valuation, investor perception and Willow’s ( TSX: WLLW ) market opportunity as it closes in on the production of commercial quantities of pharma grade CBD and rare cannabinoids were amongst a variety of topics covered in a recent conversation between Gr...
Featured Submission | July 14, 2020 |

Increased Cannabis Interest Paves Way for Cannabinoid Production

As the cannabis market has started to recover amidst the COVID-19 pandemic, investors are looking at where the market can grow. One leading candidate is cannabinoid production. THC, CBD, and other specific cannabinoids can be useful for a variety of treatments, includ...
Omri Wallach | June 9, 2020 |

Insmed Shares Trade 40% Higher on Phase 2 Top-Line Bronchiectasis Trial Data

Insmed Inc.'s shares traded higher today after the company reported positive top-line results from its Phase 2 WILLOW Study of INS1007 in patients with non-cystic fibrosis bronchiectasis. Global biopharmaceutical company Insmed Inc. (INSM:NASDAQ) , which is...
Streetwise Reports | February 4, 2020 |

Catching up with the all the ‘Gold Hits from CCR’: Part 2

Perry Little, the CEO of Green River Gold Corp. (CCR) ( CSE.CCR , Forum ) would like to introduce QP Stephen Kocsis, P.Geo who will be involved with the company’s mineral and placer gold exploration projects. Stephen is based in Quesnel, a short drive fro...
Dave Jackson | January 21, 2021 |

Catching up with the all the ‘Gold Hits from CCR’ Part 1

When we last connected with Perry Little, the CEO of Green River Gold Corp. (CCR) ( CSE.CCR , Forum ) in a May podcast with Stockhouse Media , the effects of COVID-19 had made its negative economic impact known across the globe, but not necessarily within the metals & m...
Dave Jackson | December 16, 2020 |

Building America’s mine to battery to EV supply chain

In 2010 the US Department of Energy’s Critical Materials Strategy included lithium as one of 14 elements expected to play a vital role in America’s clean energy economy. Lithium is also among 23 critical metals President Trump has deemed ...
Richard (Rick) Mills | October 18, 2019 |